The COVID-19 pandemic has underscored the importance of APIs in the context of urgent global health needs. With the accelerated development of vaccines and therapeutic options, there is an increasing emphasis on the reliability of the supply chain for APIs. Ensuring the availability of high-quality APIs is critical for public health and requires robust manufacturing and distribution networks.
Like any medication, Theophylline may cause side effects. Common side effects include nausea, headache, and insomnia. Severe side effects, such as rapid heart rate or seizures, warrant immediate medical attention.
APIs are crucial in the development of safe and effective medications. They undergo rigorous testing for efficacy, safety, and stability before being approved for use. The process of developing an API involves several stages, including discovery, preclinical testing, clinical trials, and regulatory approval. Once an API passes these stages, it can be formulated into a drug product, which may include excipients or inactive ingredients that aid in the delivery of the active substance.
Moreover, the rise of personalized medicine means that APIs need to be adaptable to suit individual patient profiles, enhancing the efficacy of treatments. This transformation signifies a move towards more tailored healthcare solutions, with potential APIs being developed to address specific genetic markers or disease mechanisms unique to individual patients.